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Brief Communications

Aerobic Glycolysis in the Frontal Cortex Correlates with
Memory Performance in Wild-Type Mice But Not the APP/
PS1 Mouse Model of Cerebral Amyloidosis
Richard A. Harris,1 Lauren Tindale,1 Asad Lone,1 Olivia Singh,1 Shannon L. Macauley,2 Molly Stanley,2
David M. Holtzman,2 Robert Bartha,3 and Robert C. Cumming1
1

Department of Biology, University of Western Ontario, London, Ontario N6A 5B7, Canada, 2Department of Neurology, Hope Center for Neurological
Disorders, Knight Alzheimer’s Disease Research Center, Washington University School of Medicine, St. Louis, Missouri 63110, and 3Department of
Physiology and Pharmacology, University of Western Ontario, and Molecular Brain Research Group, Robarts Research Institute, London, Ontario N6A 5B7,
Canada

Aerobic glycolysis and lactate production in the brain plays a key role in memory, yet the role of this metabolism in the cognitive decline
associated with Alzheimer’s disease (AD) remains poorly understood. Here we examined the relationship between cerebral lactate levels and
memory performance in an APP/PS1 mouse model of AD, which progressively accumulates amyloid-␤. In vivo 1H-magnetic resonance spectroscopy revealed an age-dependent decline in lactate levels within the frontal cortex of control mice, whereas lactate levels remained unaltered
in APP/PS1 mice from 3 to 12 months of age. Analysis of hippocampal interstitial fluid by in vivo microdialysis revealed a significant elevation in
lactate levels in APP/PS1 mice relative to control mice at 12 months of age. An age-dependent decline in the levels of key aerobic glycolysis
enzymes and a concomitant increase in lactate transporter expression was detected in control mice. Increased expression of lactate-producing
enzymes correlated with improved memory in control mice. Interestingly, in APP/PS1 mice the opposite effect was detected. In these mice,
increased expression of lactate producing enzymes correlated with poorer memory performance. Immunofluorescent staining revealed localization of the aerobic glycolysis enzymes pyruvate dehydrogenase kinase and lactate dehydrogenase A within cortical and hippocampal neurons
in control mice, as well as within astrocytes surrounding amyloid plaques in APP/PS1 mice. These observations collectively indicate that
production of lactate, via aerobic glycolysis, is beneficial for memory function during normal aging. However, elevated lactate levels in APP/PS1
mice indicate perturbed lactate processing, a factor that may contribute to cognitive decline in AD.
Key words: aerobic glycolysis; Alzheimer’s disease; amyloid; lactate; magnetic resonance spectroscopy; memory

Significance Statement
Lactate has recently emerged as a key metabolite necessary for memory consolidation. Lactate is the end product of aerobic glycolysis, a
unique form of metabolism that occurs within certain regions of the brain. Here we detected an age-dependent decline in the expression
of aerobic glycolysis enzymes and a concomitant decrease in lactate levels within the frontal cortex of wild-type mice. Improved memory
performance in wild-type mice correlated with elevated expression of aerobic glycolysis enzymes. Surprisingly, lactate levels remained
elevated with age and increased aerobic glycolysis enzyme expression correlated with poorer memory performance in APP/PS1 mice.
These findings suggest that while lactate production is beneficial for memory in the healthy aging brain, it might be detrimental in an
Alzheimer’s disease context.

Memory consolidation and retrieval are energetically demanding
processes. Cerebral activation is quickly followed by a regional

increase in blood flow, glucose uptake, and glycolytic metabolism
(Fox et al., 1988). The astrocyte–neuron lactate shuttle hypothesis posits that astrocytes process glucose by aerobic glycolysis to
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generate lactate as a metabolic intermediate, which is subsequently used as a primary fuel source for neurons (for review, see
Magistretti and Allaman, 2015). Aerobic glycolysis can be described as the reliance on glycolysis, even when oxygen is not
rate-limiting, with the concomitant production of lactate as a
by-product (Lunt and Vander Heiden, 2011). Emerging evidence
suggests that lactate production and transport between astrocytes
and neurons is required for long-term memory formation (Newman et al., 2011; Suzuki et al., 2011). Lactate has also been identified as a novel signaling molecule in the brain (Mosienko et al.,
2015) responsible for induced expression of genes associated with
synaptic plasticity (Yang et al., 2014).
Alzheimer’s disease (AD) is the most common form of
dementia among the elderly and is characterized by the accumulation of cerebral plaques primarily composed of amyloid-␤peptide (A␤). Although aberrant A␤ processing and accumulation has
strongly been associated with AD, the exact cause of dementia in
AD patients is still poorly defined. Recent studies revealed that a
reduction in cerebral metabolism precedes neurodegeneration, is
closely linked with amyloid pathology, and correlates with cognitive decline in AD (Mosconi et al., 2006). In addition to cell
loss, cerebral hypometabolism in the AD brain may arise, in part,
by A␤ deposition, which is known to disturb mitochondrial function, leading to impaired energy metabolism (Atamna and Frey,
2007). A recent positron emission tomography (PET) imaging
study revealed a strong correlation between the spatial distribution of aerobic glycolysis and A␤ deposition in the human brain
(Vlassenko et al., 2010). Thus aerobic glycolysis may represent an
adaptive mechanism that permits sufficient energy production
regardless of A␤-mediated impairment of mitochondrial respiration. However, it is currently unknown whether aerobic glycolysis and the associated production of lactate is either beneficial or
detrimental in an AD context.
Here we examined CNS metabolism within an APP/PS1
mouse model of AD to test the hypothesis that lactate production
in the brain plays a key role in memory formation and is altered
by amyloid deposition with age. Our findings suggest that lactate
production in the frontal cortex declines naturally with age and
expression of enzymes that contribute to its production correlates highly with improved memory performance in control
mice, but not in APP/PS1 mice.

Materials and Methods
Animals. Male APPswe/PSEN1dE9 mice (Jankowsky et al., 2001) were
maintained on a C57BL/6J background (Charles River Laboratories International), henceforth referred to as APP/PS1 mice. All animals were
housed under a 12 h light/dark cycle with ad libitum access to breeder
chow base diet (Mouse Diet 5015, LabDiet) in compliance with the Canadian Council of Animal Care guidelines. Spatial memory was assessed
as previously described (Morris, 1984) using the Morris water maze
(MWM).
1
H magnetic resonance spectroscopy. Mice were anesthetized with 2%
isoflurane and scanned using a 9.4 T small-animal MRI scanner
equipped with a 30 mm millipede volume radiofrequency coil (Agilent). T2-weighted images were acquired and a voxel (2 ⫻ 4 ⫻ 3 mm 3)
was localized to the frontal cortex for magnetic resonance spectroscopy (MRS) using a LASER (localization by adiabatic selective refocusing) pulse sequence with the following parameters: TR/TE ⫽
4000/270 ms, 384 averages for the metabolite spectrum with water
suppressed. An unsuppressed water spectrum (eight averages) was
also acquired and QUECC (QUALITY deconvolution and eddy current correction) was applied to correct for lineshape distortion (Bartha et al., 2000). Metabolite spectra were fitted using fitMAN software
incorporated into a graphical user interface written in the IDL (Inter-

active Data Language) programming language (Kassem and Bartha,
2003).
In vivo microdialysis and interstitial fluid lactate measurements. The
interstitial fluid (ISF) of the hippocampus was sampled using in vivo
microdialysis at a flow rate of 1 l/min. Hippocampal ISF was sampled
hourly for 6 – 8 h and ISF lactate concentrations were quantified on a YSI
2900 analyzer (YSI) as previously described (Macauley et al., 2015).
Western blot analysis and of brain extracts. Following perfusion with
Dulbecco’s PBS (DPBS), pH 7.4, the brains of mice were removed and the
frontal cortex of the right hemisphere was homogenized in an extraction
buffer containing 50 mM Tris, pH 7.5, 2% SDS, and protease and phosphatase inhibitors. Protein extracts were resolved by 10% SDS-PAGE,
and electroblotted onto a PVDF membrane (Bio-Rad). Membranes were
probed with the following antibodies: pyruvate dehydrogenase kinase
(PDK1; Enzo Life Sciences), pyruvate dehydrogenase-E1␣ (PDH-E1␣;
pSer 232; Calbiochem), PDH-E1␣ (Abcam), lactate dehydrogenase B
(LDHB; Abcam), monocarboxylate transporter isoform 2 (MCT2),
monocarboxylate transporter isoform 4 (MCT4; Millipore), lactate dehydrogenase A (LDHA), pyruvate kinase-M2 isoform (PKM2), pyruvate
kinase-M1 isoform (PKM1), and ␤-actin (Cell Signaling Technology).
Incubation followed with an appropriate horseradish peroxidaseconjugated secondary antibody (Bio-Rad). The blots were developed
using Pierce ECL Western blotting substrate (ThermoFisher Scientific)
and visualized with a Bio-Rad Molecular Imager (ChemiDoc XRS, BioRad). Densitometric analysis was performed using Quantity One software (Bio-Rad).
Preparation of mouse brain soluble and insoluble A␤ extracts and
ELISAs. Mouse brain tissue from the frontal cortex was extracted as
described above, sonicated briefly, and centrifuged at 100,000 ⫻ g for 1 h
at 4°C. The supernatant was collected as the soluble A␤ fraction and
initially diluted in cold reaction buffer (DPBS containing 5% BSA and
0.03% Tween 20). For the insoluble A␤ fraction, the pellet was dissolved
in 70% formic acid and sonicated briefly before centrifugation at
100,000 ⫻ g for 1 h at 4°C. ELISAs for A␤40 and A␤42 (Life Technologies) were performed according to the manufacturer’s instructions.
Immunohistochemistry and confocal microscopy. Left hemibrains were
fixed in 4% paraformaldehyde at 4°C overnight, then incubated in 30%
sucrose at 4°C for 48 h, and snap frozen in O.C.T. compound (TissueTek). Brain tissues were sectioned on a serial sagittal plane at 30 m and
free-floating brain slices were washed in PBS, permeabilized using PBST
(PBS and 0.1% Triton X-100), and then blocked overnight at 4°C in 10%
goat serum in PBST. Sections were incubated in the following primary
antibody solutions in PBS overnight at 4°C: PDK1 (Enzo Life Sciences),
LDHA (Cell Signaling Technology), GFAP (Abcam), and TUJ1 (Abcam).
Sections were washed in PBS and incubated in secondary antibodies
Alexa Fluor 488 and Alexa Fluor 647 (Life Technologies) for 1 h at room
temperature. For staining of A␤ plaques, sections were dehydrated with
80% ethanol and then incubated in 0.01% thioflavin S (Sigma-Aldrich)
for 15 min at room temperature, followed by rehydration in PBS and
mounting with ProLong Gold antifade reagent (Life Technologies) on
slides.
Statistical analysis. Two-way ANOVA and Tukey’s post hoc comparisons were used to analyze the difference between the genotypes over the
course of aging for lactate levels deduced by 1H-MRS analysis and the
genotypes at different ages for band intensity derived from Western blot
band densitometry. For in vivo microdialysis of ISF lactate levels, a oneway or two-way ANOVA and post hoc tests were performed. A two-factor
linear regression model was used to analyze the difference between genotypes for correlation of memory performance in the MWM and relative band intensity by Western blot. Statistical evaluation was performed
using RStudio v0.97.551.

Results
Lactate levels in the frontal cortex decline with age in control mice
but are maintained in APP/PS1 mice
To examine changes to brain lactate levels over the course of
normal aging, in vivo 1H-MRS was performed on the frontal
cortex of control and APP/PS1 mice (Fig. 1A). Lactate was identified as a peak at 1.33 ppm (Fig. 1B) and quantified as a ratio to
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Figure 1. Lactate levels are elevated in the cortex and hippocampus of aged APP/PS1 mice. A, Volume of interest in frontal cerebral cortex in the coronal plane. B, Representative spectrum
showing the raw data (red line) obtained from the cortex of a 6-month-old APP/PS1 mouse, the fitted result (green line), and the residual line (blue line), which is the difference between the fit and
the spectrum. Cho, Choline; Cr, creatine; Lac, lactate (highlighted by vertical red lines between 1.2 and 1.4 ppm); NAA, N-acetylaspartate. C, Quantification of average lactate as a ratio to total NAA
for control mice and APP/PS1 mice (n ⫽ 5 and n ⫽ 12, respectively, for ages 3–9 months; n ⫽ 4 and n ⫽ 3, respectively, for age 12 months). D, Hippocampal ISF lactate levels in APP/PS1 mice are
significantly elevated at 12 and 18 months of age compared with 3-month-old mice. E, A significant difference in hippocampal ISF lactate levels between control and APP/PS1 mice was detected at
12 months of age. *p ⬍ 0.05, **p ⬍ 0.01, ***p ⬍ 0.001. Data are shown as mean ⫾ SEM.

the standard metabolite N-acetylaspartate. Lactate was measured
at 3, 6, 9, and 12 months of age (Fig. 1C) and a two-way ANOVA
(age ⫻ genotype) followed by a Tukey’s post hoc comparison test
was performed. This analysis revealed a significant effect of age
(F(3,44) ⫽ 5.105, p ⫽ 0.004) and interaction between age and
genotype (F(3,44) ⫽ 3.288, p ⫽ 0.029). Cortical lactate levels were
observed to progressively decline starting at 9 months of age ( p ⫽
0.008). In contrast, cortical lactate levels did not significantly
change for APP/PS1 mice throughout the course of aging. To rule
out the possibility that the anesthetic isoflurane might influence
brain metabolism during MRS analysis, in vivo microdialysis was
performed in awake, freely moving mice to assess lactate levels in
the hippocampal ISF (Fig. 1 D, E). A one-way ANOVA followed
by a Tukey’s post hoc test revealed a significant age-dependent
rise in lactate levels in APP/PS1 mice from 3 to 18 months of
age (F(2,84) ⫽ 20.53, **p ⬍ 0.01, ***p ⬍ 0.001). Furthermore,
hippocampal ISF lactate levels were significantly elevated in
APP/PS1 mice at 12 months of age compared with control mice
using a two-way ANOVA followed by a Bonferroni’s post hoc test
(F(1,75) ⫽ 5.870, *p ⬍ 0.05). These observations reveal an agedependent elevation in lactate levels within the cortex and hippocampus of APP/PS1 mice compared with control mice.
Age-dependent decline in aerobic glycolysis enzyme expression in
the frontal cortex
To explore the mechanism by which lactate levels change in the
brain with age, we next examined the expression of proteins re-

sponsible for lactate production, consumption, or transport (Fig.
2A) within the frontal cortex of control and APP/PS1 mice at 6
and 12 months of age by Western blot analysis (Fig. 2B). A twoway ANOVA (age ⫻ genotype) analysis of band intensity (Fig.
2C) revealed a significant age-dependent decline for markers of
aerobic glycolysis, including the following: PDK1 (F(1,12) ⫽
39.677, p ⬍ 0.001), PDH-p/PDH (F(1,12) ⫽ 9.006, p ⫽ 0.011),
LDHA (F(1,12) ⫽ 24.008, p ⬍ 0.001), LDHB (F(1,12) ⫽ 4.720, p ⫽
0.050), PKM2 (F(1,12) ⫽ 7.168, p ⫽ 0.020), and PKM1 (F(1,12) ⫽
22.118, p ⬍ 0.001). In contrast, lactate transporter expression was
elevated with age in control mice (MCT2: F(1,12) ⫽ 5.590, p ⫽
0.036*; MCT4: F(1,12) ⫽ 38.685, p ⬍ 0.001***). These observations collectively suggest an age-dependent decline in aerobic
glycolysis in the frontal cortex of both control mice and APP/PS1
mice, yet a compensatory increase in lactate transporter expression may occur in control mice.
Inverse relationship between aerobic glycolysis enzyme expression
and memory performance in APP/PS1 mice
To determine whether aerobic glycolysis in the frontal cortex
affects memory, the expression of aerobic glycolysis enzymes was
compared with individual performances in the MWM at 12
months of age (Fig. 3A). A multiple linear regression model (relative band intensity ⫻ genotype) was then performed on the
percentage of time spent in the correct quadrant during the probe
trial. This analysis revealed a significant interaction for enzymes
involved in lactate production (LDHA: R 2 ⫽ 0.740, p ⫽ 0.008;
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Figure 2. Age-dependent decline in expression of aerobic glycolysis proteins in the frontal cortex. A, Metabolic pathway of enzymes involved in aerobic glycolysis and lactate production includes
pyruvate dehydrogenase kinase 1 (PDK1), lactate dehydrogenase A (LDHA), and pyruvate kinase M2 (PKM2). Enzymes that favor oxidative phosphorylation include lactate dehydrogenase B (LDHB),
pyruvate kinase M1 (PKM1), and pyruvate dehydrogenase (PDH). Moncarboxylate transporter 4 (MCT4) and monocarboxylate transporter 2 (MCT2) are involved in shuttling lactate between
astrocytes and neurons, respectively. B, Western blot analysis of mouse cortical extracts from 6-month-old and 12-month-old control mice and APP/PS1 mice using the indicated antibodies. C,
Quantification of band densitometry of Western blots for markers of aerobic glycolysis and lactate production relative to ␤-actin shown as a ratio to 6 months control levels. *p ⬍ 0.05, **p ⬍ 0.01,
***p ⬍ 0.001. Data are shown as mean ⫾ SEM.
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Figure 3. Inverse relationship between aerobic glycolysis enzyme expression and memory performance in APP/PS1 mice. A, Memory performance in the MWM correlated with the expression of aerobic
glycolysisenzymesinthefrontalcortexofbothcontrolmice(n⫽6)andAPP/PS1mice(n⫽6)at12monthsofage.Higherexpressionofenzymesinvolvedinlactateproduction,includinglactatedehydrogenase
A (LDHA), pyruvate kinase M2/M1 ratio (PKM2/PKM1) and phospho-pyruvate dehydrogenase versus total pyruvate dehydrogenase (PDK-p/PDH) correlated with better memory performance for control mice,
but not for APP/PS1 mice. Higher expression of lactate dehydrogenase B (LDHB), an enzyme that consumes lactate, correlated with decreased memory performance for control mice, but an increase in memory
performanceforAPP/PS1mice.B,LevelsofA␤(1– 40)/A␤(1– 42) inbothsoluble(left)andinsoluble(right)corticalextractsfromAPP/PS1miceat12monthsofagewerecorrelatedwithLDHAandLDHBexpression.
An inverse trend between A␤1– 42 levels and LDHA was detected. Increased levels of A␤(1– 42) weakly correlated with elevated expression of LDHB. *p ⬍ 0.05, **p ⬍ 0.01.

PKM2/PKM1: R 2 ⫽ 0.662, p ⫽ 0.028; PDH-p/PDH: R 2 ⫽ 0.569,
p ⫽ 0.046), suggesting that higher expression of these proteins
correlates with better memory performance in control mice and
worse performance in APP/PS1 mice. Interestingly, an inverse

relationship was observed for LDHB, an enzyme that consumes
lactate. Higher LDHB expression correlated with a decline in
memory performance in control mice, yet showed a trend toward
improved memory performance in APP/PS1 mice (R 2 ⫽ 0.522,
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p ⫽ 0.180). To examine the relationship
between A␤ load and enzyme expression,
ELISA analysis of A␤ levels in APP/PS1
mice at 12 months of age was performed
(Fig. 3B). Increased levels of A␤(1– 42)
weakly correlated with decreased expression of LDHA (R 2 ⫽ 0.221, p ⫽ 0.113),
whereas a positive correlation was noted
for LDHB expression (R 2 ⫽ 0.194, p ⫽
0.133). No significant association or trend
was observed between A␤ levels and expression of other enzymes involved in
aerobic glycolysis (data not shown). Altogether these data suggest that lactate
production in the frontal cortex may contribute to improved memory processing
in control mice, yet may in fact be detrimental to APP/PS1 mice. In addition, elevated levels of A␤(1– 42), but not A␤(1– 40),
may promote increased consumption
rather than production of lactate in APP/
PS1 mice.
PDK1 and LDHA are expressed in both
astrocytes and neurons
To our knowledge, the spatial expression
of enzymes responsible for aerobic glycolysis and lactate production in the mouse
brain with age has not been examined. To
identify which cell types are expressing the
enzymes responsible for aerobic glycolysis
and lactate production, frozen brain sections from control and APP/PS1 mice at
12 months old were immunostained using
antibodies specific for PDK1 and LDHA
and costained with antibodies for astrocytes
(GFAP) and neurons (TUJ1). Within the
frontal cortex of control mice, PDK1 and
LDHA expression was localized primarily
to the soma of TUJ1⫹ neurons (Fig. 4A).
Interestingly, in the frontal cortex of APP/
PS1 mice, PDK1 and LDHA were primarily expressed in the soma of TUJ1⫹
neurons, yet were also expressed in GFAP⫹
reactive astrocytes surrounding amyloid
plaques (Fig. 4B). These observations indicate that PDK1 and LDHA are expressed primarily in the cell bodies of
neurons, yet both cell types may be capable of producing lactate through aerobic
glycolysis.

Discussion
This study revealed that age-dependent
alterations in lactate metabolism are
strongly associated with memory in both
control and transgenic AD mice but in opposite ways. Metabolic coupling of astrocytes and neurons in the brain has been
examined extensively, yet little emphasis
has been placed on examining changes in
this metabolism with age. In this study,
1
H-MRS analysis of the frontal cortex re-

Figure 4. PDK1 and LDHA expression is primarily restricted to the soma of neuron-specific class III beta-tubulin positive
(TUJ1⫹) neurons in the frontal cortex and also glial fibrillary acidic protein positive (GFAP⫹) reactive astrocytes surrounding
plaques in APP/PS1 mice. A, B, Fluorescence micrographs of the frontal cortex in control mice (A) and APP/PS1 mice (B) at 12
months of age. Thioflavin S was used to visualize amyloid plaque deposits (blue) while immunofluorescence was used to colocalize
expression of PDK1 (red) and LDHA (red) with markers for astrocytes (GFAP⫹, green) and neurons (TUJ1⫹, red). Merged images
indicate that PDK1 and LDHA are expressed primarily in the soma of TUJ1⫹ neurons. White arrows indicate colocalized expression
of PDK1 and LDHA in cortical GFAP⫹ cells in APP/PS1 mice. Scale bar, 100 m.
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vealed a decline in lactate levels with age for control mice,
whereas lactate levels remained elevated in older APP/PS1 mice.
Furthermore, hippocampal ISF lactate levels were elevated in
APP/PS1 mice relative to control mice at 12 months of age, a time
point when cognitive deficits occur in transgenic mice. In support of our findings, a recent 1H-MRS longitudinal study of metabolites in healthy C57BL/6 mice between 3 and 24 months of
age also revealed a progressive decline in lactate levels in the
cortex but not hippocampus (Duarte et al., 2014). In contrast, an
earlier study using 1H-MRS reported that cortical lactate levels
increase with age in a mitochondrial DNA mutator mouse model
of advanced aging, an event associated with an increase in the
ratio of LDHA to LDHB (Ross et al., 2010).
Few 1H-MRS studies measuring lactate in the aging human
brain have been conducted. In one report, lactate levels increased
in the left frontal lobe of young subjects (19 –24 years old), but
not in healthy aged subjects (60 – 68 years old), engaged in a silent
word-generation task (Urrila et al., 2004). Elevated lactate levels
within the precuneus/posterior cingulate of individuals with mild
cognitive impairment were recently found to negatively correlate
with memory performance (Weaver et al., 2015). In addition, AD
patients show a significant increase in CSF lactate levels compared with age-matched nondemented individuals or patients
with vascular dementia (Liguori et al., 2015). Finally, intravenous
lactate infusion does not improve semantic memory in AD patients (Kálmán et al., 2005). Collectively, these observations suggest that elevated cerebral lactate may actually interfere with
memory processes in AD.
The mechanism by which A␤ alters glycolytic metabolism is
poorly defined. An A␤-stimulated increase in glucose uptake in
the cortex and hippocampus has previously been reported in
12-month-old APP/PS1 mice (Poisnel et al., 2012). Moreover,
induction of acute hyperglycemia resulted in increased hippocampal ISF lactate levels and neuronal activity in APP/PS1
mice (Macauley et al., 2015). Our observation of elevated lactate
levels in the frontal cortex and hippocampus of APP/PS1 mice at
12 months of age compared with controls may be explained by
enhanced glucose uptake and neuronal activity. It is also possible
that lactate transport is compromised in the aging brain or is
negatively affected by A␤ deposition. Unexpectedly, we observed
an inverse correlation between A␤(1– 40) and A␤(1– 42) levels with
LDHA and LDHB expression in the cortex. Further investigation
is warranted to determine the exact changes in lactate metabolism
that occur as a consequence of the aging process and in an AD
context.
Lactate production and transport between astrocytes and neurons are required for learning and long-term memory formation
(Newman et al., 2011; Suzuki et al., 2011). Our results indicate
that control mice with higher expression of lactate-producing
enzymes in the frontal cortex have improved memory. These
observations suggest that lactate production in the frontal cortex
is a key determinant of memory function and implicate aerobic
glycolysis as a mechanism to supply fuel to active regions of the
brain (Vlassenko et al., 2006). Lactate has been shown to potentiate NMDA receptor-mediated signaling by modulating the redox state in neurons and also by inducing expression of genes
associated with synaptic plasticity (Barros, 2013; Yang et al.,
2014).
Paradoxically, we observed a decline in memory performance
in APP/PS1 mice that correlated with increased expression of
lactate-producing enzymes and elevated ISF hippocampal lactate
levels. Multimodal PET imaging measuring A␤ deposition, glucose consumption, and oxygen utilization revealed a strong cor-
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relation between the spatial distribution of elevated aerobic
glycolysis and A␤ deposition in brain tissue (Vlassenko et al.,
2010). We previously demonstrated that nerve cells selected for
resistance to A␤ toxicity upregulate aerobic glycolysis as a protective mechanism (Newington et al., 2012). It is possible that
elevated aerobic glycolysis occurs during the prodromal phase of
AD as a compensatory mechanism to mitigate the toxic effects of
A␤ accumulation and maximize energy utilization. However,
during progression of the disease, aerobic glycolysis and lactate
production may in fact be detrimental and contribute to the cognitive decline associated with AD.
In this study, we observed that PDK1 and LDHA (both markers of aerobic glycolysis) are expressed primarily in the soma of
neurons in the frontal cortex of control mice and of both neurons
and astrocytes surrounding plaques in the frontal cortex of APP/
PS1 mice. This observation suggests that neurons are capable of
generating lactate, although the purpose of neuron-derived lactate remains unclear. It has recently been suggested that lactate,
not pyruvate, is the primary end product of glycolysis in fully
oxygenated cells, including neurons (Rogatzki et al., 2015). Lactate may be produced as a metabolic intermediate in the cytosol
that is shuttled into the mitochondria to be oxidized as a fuel
source (Stainsby and Brooks, 1990). Interestingly, genetic manipulation of metabolism to promote increased lactate production
results in oxidative stress and apoptosis within rat cortical neurons but not in astrocytes (Herrero-Mendez et al., 2009). It is
possible that elevated intracellular lactate promotes neuronal
death in AD. Further investigation is warranted to elucidate the
exact role of lactate production, consumption, or transport in
astrocytes and neurons to identify key molecular targets for therapeutic treatment of AD.
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